First safety check: new drug meets common meds
NCT ID NCT07446400
Summary
This early-stage study aims to see how a new drug called repinatrabit interacts with several common medications, including birth control, diabetes, and cholesterol drugs. It will involve 48 healthy volunteers to measure drug levels in the blood and check for safety. The goal is to gather basic information to see if these drugs can be taken together safely in future patient studies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.